International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AE) United Arab Emirates: Edronax;
-
(AR) Argentina: Prolift;
-
(AT) Austria: Edronax;
-
(AU) Australia: Edronax;
-
(BE) Belgium: Edronax;
-
(BG) Bulgaria: Edronax;
-
(BR) Brazil: Prolift;
-
(CH) Switzerland: Edronax;
-
(CL) Chile: Prolift;
-
(CN) China: Reboxetine mesylate | Zuo le xin;
-
(CO) Colombia: Integrex;
-
(CZ) Czech Republic: Edronax;
-
(DE) Germany: Edronax | Solvex;
-
(DO) Dominican Republic: Edronax;
-
(EC) Ecuador: Edronax;
-
(EE) Estonia: Edronax;
-
(EG) Egypt: Edronax | Senorein;
-
(ES) Spain: Irenor | Norebox;
-
(FI) Finland: Edronax;
-
(GB) United Kingdom: Edronax;
-
(HR) Croatia: Edronax;
-
(HU) Hungary: Edronax;
-
(IE) Ireland: Edronax;
-
(IL) Israel: Edronax;
-
(IN) India: Narebox | Reboot | Rebotin | Reboxxin;
-
(IT) Italy: Davedax | Edronax;
-
(LB) Lebanon: Edronax;
-
(LT) Lithuania: Edronax;
-
(LU) Luxembourg: Edronax;
-
(LV) Latvia: Edronax;
-
(MX) Mexico: Edronax;
-
(NO) Norway: Edronax;
-
(NZ) New Zealand: Edronax;
-
(PE) Peru: Edronax;
-
(PL) Poland: Edronax;
-
(PT) Portugal: Edronax;
-
(RO) Romania: Edronax;
-
(SE) Sweden: Edronax;
-
(SI) Slovenia: Edronax;
-
(SK) Slovakia: Edronax;
-
(TH) Thailand: Edronax;
-
(TR) Turkey: Edronax;
-
(VE) Venezuela, Bolivarian Republic of: Prolift;
-
(ZA) South Africa: Edronax
Pharmacologic Category
-
Norepinephrine Reuptake Inhibitor, Selective
Reported Use
Treatment of major depressive disorder (MDD)
Dosage Range
Oral:
Adults: 4 mg twice daily (8 mg/day); after 3 to 4 weeks, may increase dose to 10 mg/day (maximum: 12 mg/day)
Elderly (>65 years): 2 mg twice daily (4 mg/day); after 3 to 4 weeks, may increase dose to 6 mg/day
Dosing adjustment in hepatic/renal impairment: 2 mg twice daily; may increase every 3 to 4 weeks as tolerated
Product Availability
Product available in various countries; not currently available in the US
Dosage Forms
Tablet: 4 mg